Market Closed -
Other stock markets
|
Pre-market 08:45:19 am | |||
159.6 USD | -4.58% | 158.8 | -0.53% |
02:31pm | Barclays Adjusts Price Target on AbbVie to $187 From $195 | MT |
Apr. 26 | Health Care Flat After Strong Earnings Week -- Health Care Roundup | DJ |
Evolution of the average Target Price on AbbVie Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AbbVie Inc.
Deutsche Bank Securities | |
Barclays | |
UBS | |
Truist Securities | |
Piper Sandler | |
Morningstar | |
Wells Fargo Securities | |
Goldman Sachs | |
BMO Capital | |
Raymond James | |
William Blair & Co. | |
BofA Securities | |
HSBC | |
Morgan Stanley | |
Guggenheim | |
Argus | |
Wolfe Research | |
Atlantic Equities | |
SVB Securities LLC | |
Credit Suisse | |
Societe Generale | |
Berenberg Bank | |
JPMorgan Chase | |
Cowen | |
Redburn | |
Mizuho Securities | |
SVB Leerink | |
Daiwa Securities | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- ABBV Stock
- Consensus AbbVie Inc.